Principal Investigators

    Anders M. Fjell

    Institution

    University Of Oslo

    Contact information of lead PI

    Country

    Norway

    Title of project or programme

    Inflammation, Amyloid and Atrophy in The Aging Brain: The Borders between Healthy Brain Aging and Neurodegeneration

    Source of funding information

    RCN

    Total sum awarded (Euro)

    € 7,299,688

    Start date of award

    01/10/2014

    Total duration of award in years

    3.5

    The project/programme is most relevant to:

    Alzheimer's disease & other dementias

    Keywords

    Research Abstract

    How the link between aging and AD should be understood is a major question in contemporary neuroscience. Evidence is mounting that Alzheimer-vulnerable neural systems are highly susceptible to a number of different factors in aging, with some being diseas e related while others are not. Our aim is to identify fundamental mechanisms causing these systems to decline also in non-demented elderly, allowing us to address the overarching question of why do some people maintain cognitive abilities in higher age w hile others decline? First, using 1100 cross-sectional and 207 longitudinal examinations, we will compute detailed age-vulnerability maps for a range of brain characteristics representing different neurobiological traits. In Part 2, we will launch the most intensive study of normal aging to date in an attempt to understand mechanisms and moderators of the vulnerabilities identified in Part 1. In an independent sample of 200 healthy participants (25-90 yrs), we will obtain extremely comprehensive longitudinal measures of brain structure and function, cognition, genes and life-style factors. The most novel aspect is that we simultaneously map distribution of amyloid deposition and neuro-inflammation (PET), which has not previously been done. This is striking, as there is evidence for a relationship between amyloid and neuro-inflammation from animal studies, and effects of amyloid on brain health in non-demented is a major area of research. Also, life-style related risk factors for cognitive decline, such as overweight, blood pressure and cholesterol, are hypothesized to impact the brain partly through neuro-inflammation. Thus, systematic testing of how amyloid and neuro-inflammation are related to each other and to cerebral and cognitive change in non-demented, and the possibly mediating roles played by life-style and genetic risk factors, has the potential to really push the boarders of our understanding of brain aging, thereby opening new venues for intervention.

    Lay Summary

    Further information available at:

Types: Investments > €500k
Member States: Norway
Diseases: Alzheimer's disease & other dementias
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF